{"title":"自体填充物治疗中重度鼻唇褶皱的有效性:一项初步研究。","authors":"Angela Cong, LaRyel Waldon, Aurelio Aquila, Sharon Stewart, Amit Kochhar, Kian Karimi","doi":"10.1089/fpsam.2024.0253","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Nasolabial folds, commonly known as smile lines, are a cosmetic concern for individuals. <b>Objective:</b> To measure the change in facial volume at the nasolabial folds among adults injected with an autologous blood filler, as measured by three-dimensional (3D) photography and aesthetic surveys. <b>Methods:</b> Fifteen participants above the age of 22 received up to three autologous filler injections, to bilateral nasolabial folds, over a 24-week treatment period. Based on investigator's discretion, injections ranged from 0.6 to 3.0 cc at the initial visit, week 4, and week 16. Follow-ups were conducted at weeks 2, 6, 8, 20, and 24 with measurements completed at the beginning of each treatment and follow-up visit. Standardized 3D photography with Vectra® and QuantifiCare® cameras measured volume for before and after comparison. Patients and investigator completed the Wrinkle Severity Rating Scale and Global Aesthetic Improvement Scale. <b>Results:</b> Fifteen patients, 1 male and 14 female, age 32-63, were followed-up for 24 weeks. The treatment improved nasolabial fold appearances and patient satisfaction. The 3D imaging revealed increased volume in the treated areas. <b>Conclusion:</b> The autologous filler effectively fills moderate-to-severe nasolabial folds in this pilot study and future studies are needed to evaluate safety.</p>","PeriodicalId":48487,"journal":{"name":"Facial Plastic Surgery & Aesthetic Medicine","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effectiveness of an Autologous Filler in Patients with Moderate-to-Severe Nasolabial Folds: A Pilot Study.\",\"authors\":\"Angela Cong, LaRyel Waldon, Aurelio Aquila, Sharon Stewart, Amit Kochhar, Kian Karimi\",\"doi\":\"10.1089/fpsam.2024.0253\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Nasolabial folds, commonly known as smile lines, are a cosmetic concern for individuals. <b>Objective:</b> To measure the change in facial volume at the nasolabial folds among adults injected with an autologous blood filler, as measured by three-dimensional (3D) photography and aesthetic surveys. <b>Methods:</b> Fifteen participants above the age of 22 received up to three autologous filler injections, to bilateral nasolabial folds, over a 24-week treatment period. Based on investigator's discretion, injections ranged from 0.6 to 3.0 cc at the initial visit, week 4, and week 16. Follow-ups were conducted at weeks 2, 6, 8, 20, and 24 with measurements completed at the beginning of each treatment and follow-up visit. Standardized 3D photography with Vectra® and QuantifiCare® cameras measured volume for before and after comparison. Patients and investigator completed the Wrinkle Severity Rating Scale and Global Aesthetic Improvement Scale. <b>Results:</b> Fifteen patients, 1 male and 14 female, age 32-63, were followed-up for 24 weeks. The treatment improved nasolabial fold appearances and patient satisfaction. The 3D imaging revealed increased volume in the treated areas. <b>Conclusion:</b> The autologous filler effectively fills moderate-to-severe nasolabial folds in this pilot study and future studies are needed to evaluate safety.</p>\",\"PeriodicalId\":48487,\"journal\":{\"name\":\"Facial Plastic Surgery & Aesthetic Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-04-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Facial Plastic Surgery & Aesthetic Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/fpsam.2024.0253\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Facial Plastic Surgery & Aesthetic Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/fpsam.2024.0253","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
Effectiveness of an Autologous Filler in Patients with Moderate-to-Severe Nasolabial Folds: A Pilot Study.
Background: Nasolabial folds, commonly known as smile lines, are a cosmetic concern for individuals. Objective: To measure the change in facial volume at the nasolabial folds among adults injected with an autologous blood filler, as measured by three-dimensional (3D) photography and aesthetic surveys. Methods: Fifteen participants above the age of 22 received up to three autologous filler injections, to bilateral nasolabial folds, over a 24-week treatment period. Based on investigator's discretion, injections ranged from 0.6 to 3.0 cc at the initial visit, week 4, and week 16. Follow-ups were conducted at weeks 2, 6, 8, 20, and 24 with measurements completed at the beginning of each treatment and follow-up visit. Standardized 3D photography with Vectra® and QuantifiCare® cameras measured volume for before and after comparison. Patients and investigator completed the Wrinkle Severity Rating Scale and Global Aesthetic Improvement Scale. Results: Fifteen patients, 1 male and 14 female, age 32-63, were followed-up for 24 weeks. The treatment improved nasolabial fold appearances and patient satisfaction. The 3D imaging revealed increased volume in the treated areas. Conclusion: The autologous filler effectively fills moderate-to-severe nasolabial folds in this pilot study and future studies are needed to evaluate safety.